Therefore, BoNT-A injection (detrusor or urethral sphincter) is a viable option for effective AD control in SCI patients with refractory medical control, such as a selective alpha-1 blocker or a calcium channel blocker. This evidence concerns the gene PSMA6 and Alzheimer disease.